Alexander Kutikov
Overview
Explore the profile of Alexander Kutikov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
336
Citations
5411
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geynisman D, Abbosh P, Ross E, Zibelman M, Ghatalia P, Anari F, et al.
J Clin Oncol
. 2024 Dec;
43(9):1113-1122.
PMID: 39680823
Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care for patients with muscle-invasive bladder cancer (MIBC). Mutations in DNA damage repair genes are associated with pathologic...
2.
Bologna E, Licari L, Badani K, Razdan S, Psutka S, Ditonno F, et al.
J Robot Surg
. 2024 Oct;
18(1):369.
PMID: 39402405
Our aim was to investigate the perception and future expectations of Single-Port (SP) surgery among urology trainees in the United States. A 34-item online survey was distributed to urological residency...
3.
Marandino L, Campi R, Amparore D, Tippu Z, Albiges L, Capitanio U, et al.
Eur Urol Oncol
. 2024 Sep;
PMID: 39327187
Context: Immune-oncology strategies are revolutionising the perioperative treatment in several tumour types. The perioperative setting of renal cell carcinoma (RCC) is an evolving field, and the advent of immunotherapy is...
4.
Schober J, Kutikov A, Strother M
Urol Pract
. 2024 Sep;
12(1):17-18.
PMID: 39302183
No abstract available.
5.
Safder I, Valentine H, Uzzo N, Sfakianos J, Uzzo R, Gupta S, et al.
JCO Precis Oncol
. 2024 Aug;
8:e2300661.
PMID: 39151107
Purpose: The purpose of this study was to elucidate the relationship between the tumor microenvironment (TME) and cellular diversity in bladder cancer (BLCA) progression, leveraging single-cell RNA sequencing (scRNA-seq) data...
6.
Lee P, Ruth K, Lee D, Hallman M, Chen D, Wong J, et al.
Brachytherapy
. 2024 Jul;
23(5):559-568.
PMID: 39060143
Purpose: We aim to investigate perioperative and subacute postoperative complications in patients undergoing LDR or HDR monotherapy for prostate cancer. We hypothesize a low rate of complications, and a favorable...
7.
Esnaola N, Chelluri R, Castellanos J, Altman A, Chen D, Chu C, et al.
Ann Surg
. 2024 Jul;
281(3):395-403.
PMID: 39045699
Objective: To evaluate the efficacy of risk-based, protocol-driven management versus usual management after elective major cancer surgery to reduce 30-day rates of postoperative death or serious complications (DSCs). Background: Major...
8.
Leonard S, Helstrom E, Correa A, Sindhani M, Uzzo N, Jia A, et al.
JCO Oncol Pract
. 2024 Jul;
20(12):1755-1763.
PMID: 39008789
Purpose: This study leverages CDC National Health Interview Survey data to examine Financial Distress (FD) among genitourinary (GU) cancer survivors, specifically prostate cancer (PC), kidney cancer (KC), and bladder cancer...
9.
Satyal U, Valentine H, Liu D, Slifker M, Lallas C, Trabulsi E, et al.
JCO Precis Oncol
. 2024 Jun;
8:e2300362.
PMID: 38865671
Purpose: There is significant interest in identifying complete responders to neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) to potentially avoid removal of a pathologically benign bladder. However, clinical restaging after...
10.
Bukavina L, Ginwala R, Eltoukhi M, Sindhani M, Prunty M, Geynisman D, et al.
Cancer Res Commun
. 2024 May;
4(6):1505-1516.
PMID: 38747616
Significance: Our study highlights results that link the composition of the GM to the efficacy of NAC in MIBC. We discovered that patients with higher levels of Bacteroides experienced a...